An increased release of SFA in the tumour microenvironment stimulates macrophages to manufacture pro-inflammatory mediators, including cyclooxygenase-2 and tumour necrosis factor alpha42, leading to enhanced aromatase expression in adipocytes and sustained oestrogen biosynthesis for tumour progression43,44. The gene discussed is PTGS2; the disease is neoplasm.